Skip to content
Business Segments · Cost of revenues

Specialty Diagnostics — Cost of revenues

Thermo Fisher Scientific Specialty Diagnostics — Cost of revenues decreased by 8.4% to $657M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.2%, from $679M to $657M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026

How to read this metric

A rising ratio relative to revenue suggests margin compression, while a falling ratio indicates improved manufacturing efficiency.

Detailed definition

The direct costs attributable to the production and delivery of diagnostic products and services within the Specialty Di...

Peer comparison

Standard metric for assessing gross margin health across the life sciences industry.

Metric ID: tmo_segment_specialty_diagnostics_cost_of_revenues

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$646M$646M$646M$646M$668M$686M$679M$640M$682M$717M$657M
QoQ Change+0.0%+0.0%+0.0%+3.4%+2.7%-1.0%-5.7%+6.6%+5.1%-8.4%
YoY Change+3.4%+6.2%+2.1%+4.5%-3.2%
Range$640M$717M
CAGR+0.7%
Avg YoY Growth+2.6%
Median YoY Growth+3.4%

Frequently Asked Questions

What is Thermo Fisher Scientific's specialty diagnostics — cost of revenues?
Thermo Fisher Scientific (TMO) reported specialty diagnostics — cost of revenues of $657M in Q1 2026.
How has Thermo Fisher Scientific's specialty diagnostics — cost of revenues changed year-over-year?
Thermo Fisher Scientific's specialty diagnostics — cost of revenues decreased by 3.2% year-over-year, from $679M to $657M.
What does specialty diagnostics — cost of revenues mean?
The direct costs required to produce and sell the goods and services in the Specialty Diagnostics segment.